logo

For the Inventor, By the Inventor

Boonton, NJ, United States of America

Unigene Laboratories Inc.


USPTO Granted Patents = 33

% Expired Patents = 33.3



Trademarks = 2

Forward Citations = 454

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Nozer M Mehta (22 out of 37 patents)

silverMedal James P Gilligan (15 out of 24 patents)

bronzeMedal William Stern (14 out of 30 patents)

4.  Angelo P Consalvo (13 out of 21 patents)

5.  Christopher P Meenan (10 out of 11 patents)

6.  Martha V L Ray (9 out of 10 patents)

7.  Amy M Sturmer (4 out of 11 patents)

8.  Agnès Vignery (4 out of 6 patents)

9.  Barry N Jones (3 out of 3 patents)

10.  Martha V Ray (2 out of 2 patents)

11.  John L Sternick (1 out of 14 patents)

12.  Isaac Ghebre-Sellassie (1 out of 24 patents)

13.  George Crotts (1 out of 1 patent)

14.  Ashlesh Sheth (1 out of 1 patent)

15.  Arthur H Bertelsen (1 out of 1 patent)


Core Competencies:
Peptide Pharmaceutical
Oral Delivery
Obesity Treatment
Bacterial Host Cell
Nasal Calcitonin
Enzymatic Reactions
Bone Formation
Alpha-Amidation
Immunogenic Implant
Fast-Acting Products
Culture Media
Enzyme-Cleavable Membranes

33 patents:

1. 8378067 - Treatment for obesity (2013-02-19),
2. 8377863 - Peptide pharmaceutical for oral delivery (2013-02-19),
3. 8252580 - Bacterial host cell for the direct expression of peptides (2012-08-28),
4. RE43580 - Nasal calcitonin formulations (2012-08-13),
5. 8227241 - Bacterial host cell for the direct expression of peptides (2012-07-24),
6. 8217139 - Treatment for obesity (2012-07-10),
7. 8216822 - Bacterial host cell for the direct expression of peptides (2012-07-10),
8. 8163871 - Enzymatic reactions in the presence of keto acids (2012-04-24),
9. 8093207 - Fast-acting oral peptide pharmaceutical products (2012-01-10),
10. 8088734 - Oral delivery of peptides (2012-01-03),
11. 8076291 - Treatment for obesity (2011-12-13),
12. 7968311 - Direct expression of peptides into culture media (2011-06-28),
13. 7776826 - Method for fostering bone formation and preservation (2010-08-17),
14. 7648965 - Method for fostering bone formation and preservation (2010-01-19),
15. 7648700 - Method for fostering bone formation and preservation (2010-01-19),
Company Overview
Unigene Laboratories Inc. is a biopharmaceutical company based in Boonton, New Jersey, specializing in the development of peptide-based therapeutics. The company focuses on innovative drug delivery systems and has expertise in the fields of biotechnology and pharmaceuticals. Unigene is dedicated to advancing treatments for various medical conditions, leveraging its proprietary technologies to enhance the efficacy and safety of its therapeutic candidates. Its research initiatives aim to address unmet medical needs through cutting-edge science.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Unigene Laboratories Inc. USPTO Patent Assignee Logo
33 Patents

#2 in Boonton, NJ

#408 in New Jersey

#10,297 in US

#20,130 in the World

Boonton, NJ (US)
Boonton, NJ, United States of America

Unigene Laboratories Inc.

Forward Citations = 454

16 inventors:

goldMedal Nozer M Mehta (22 out of 37 patents)

silverMedal James P Gilligan (15 out of 24 patents)

bronzeMedal William Stern (14 out of 30 patents)

4.  Angelo P Consalvo (13 out of 21 patents)

5.  Christopher P Meenan (10 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Unigene Laboratories Inc.. Retrieved from https://idiyas.com/company/unigene-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…